title: Medicine use, heat and thermoregulation in Australian patients.
authors.forename: Peter W
authors.initials: PW
authors.lastname: Tait
mesh_terms: D000317:Adrenergic alpha-Antagonists / Q000009:adverse effects; D016907:Adverse Drug Reaction Reporting Systems; D000662:Amphetamines / Q000009:adverse effects; D014151:Anti-Anxiety Agents / Q000009:adverse effects; D000959:Antihypertensive Agents / Q000009:adverse effects; D001315:Australia; D001833:Body Temperature Regulation; D002257:Carbonic Anhydrase Inhibitors / Q000009:adverse effects; D000697:Central Nervous System Stimulants / Q000009:adverse effects; D018680:Cholinergic Antagonists / Q000009:adverse effects; D002927:Cimetidine / Q000009:adverse effects; D004232:Diuretics / Q000009:adverse effects; D006358:Hot Temperature / Q000009:adverse effects*; D006801:Humans; D006993:Hypnotics and Sedatives / Q000009:adverse effects; D013287:Illicit Drugs / Q000009:adverse effects; D007297:Inpatients; D008996:Monoamine Oxidase Inhibitors / Q000009:adverse effects; D010640:Phenothiazines / Q000009:adverse effects; D018570:Risk Assessment; D012307:Risk Factors; D013974:Thyroxine / Q000009:adverse effects
chemical_list: D000317:Adrenergic alpha-Antagonists; D000662:Amphetamines; D014151:Anti-Anxiety Agents; D000959:Antihypertensive Agents; D002257:Carbonic Anhydrase Inhibitors; D000697:Central Nervous System Stimulants; D018680:Cholinergic Antagonists; D004232:Diuretics; D006993:Hypnotics and Sedatives; D013287:Illicit Drugs; D008996:Monoamine Oxidase Inhibitors; D010640:Phenothiazines; D002927:Cimetidine; D013974:Thyroxine